JW Asset Management LLC Sells 241,789 Shares of Establishment Labs Holdings Inc. $ESTA

JW Asset Management LLC trimmed its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA – Free Report) by 9.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,451,067 shares of the company’s stock after selling 241,789 shares during the quarter. Establishment Labs accounts for 65.3% of JW Asset Management LLC’s portfolio, making the stock its largest position. JW Asset Management LLC owned approximately 0.08% of Establishment Labs worth $157,285,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Arizona State Retirement System increased its position in shares of Establishment Labs by 5.6% in the 2nd quarter. Arizona State Retirement System now owns 5,057 shares of the company’s stock valued at $434,000 after buying an additional 268 shares in the last quarter. HighTower Advisors LLC lifted its holdings in Establishment Labs by 3.2% during the second quarter. HighTower Advisors LLC now owns 9,517 shares of the company’s stock worth $817,000 after acquiring an additional 293 shares in the last quarter. Integrated Wealth Concepts LLC bought a new position in Establishment Labs during the second quarter worth about $32,000. KBC Group NV bought a new position in Establishment Labs during the first quarter worth about $28,000. Finally, Northwestern Mutual Wealth Management Co. acquired a new position in Establishment Labs in the second quarter valued at about $43,000. Institutional investors and hedge funds own 72.91% of the company’s stock.

Establishment Labs Price Performance

Shares of ESTA stock opened at $68.62 on Friday. The firm’s fifty day moving average price is $66.07 and its two-hundred day moving average price is $72.34. The company has a current ratio of 3.57, a quick ratio of 2.52 and a debt-to-equity ratio of 17.17. Establishment Labs Holdings Inc. has a 1 year low of $53.16 and a 1 year high of $97.59.

Establishment Labs (NASDAQ:ESTA – Get Free Report) last announced its quarterly earnings data on Friday, October 30th. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.09). The company had revenue of $71.99 million during the quarter, compared to the consensus estimate of $66.81 million. Establishment Labs had a negative net margin of 14.56% and a negative return on equity of 196.38%. Establishment Labs’s revenue was up 33.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.38) EPS. As a group, analysts expect that Establishment Labs Holdings Inc. will post -1.18 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on ESTA shares. Citigroup upgraded Establishment Labs from a “neutral” rating to a “buy” rating and set a $92.00 price target for the company in a report on Thursday, August 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Establishment Labs in a research report on Monday, September 21st. Canaccord Genuity Group set a $105.00 target price on Establishment Labs in a research note on Thursday, August 6th. Needham & Company LLC raised their target price on shares of Establishment Labs from $86.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Finally, TD Cowen cut their price target on shares of Establishment Labs from $117.00 to $95.00 and set a “buy” rating on the stock in a research note on Monday, October 26th. Nine investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Establishment Labs currently has an average rating of “Moderate Buy” and an average target price of $95.00.

View Our Latest Research Report on Establishment Labs

Establishment Labs Profile

(Free Report)

Establishment Labs Holdings Inc. is a medical technology company focused on breast health and aesthetics. Founded in 2004 by Juan José Chacón-Quirós, the Costa Rica-based company develops and manufactures products for breast augmentation and reconstruction. Its product portfolio includes Motiva breast implants, offered in different shapes and designs, as well as related technologies and products for plastic and reconstructive surgery. The company also develops solutions intended to support surgical procedures and patient care.

Featured Stories

Want to see what other hedge funds are holding ESTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Establishment Labs Holdings Inc. (NASDAQ:ESTA – Free Report).

Institutional Ownership by Quarter for Establishment Labs (NASDAQ:ESTA)

Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.